Leveraging our immune system to fight tumors is becoming a frontline therapy for cancer treatments. Yet, in the battle against cancer, our immune cells can become exhausted and lose their tumor-killing potential. Christopher Medina’s research focuses on understanding the mechanisms of immune cell dysfunction at both a metabolic and protein level to help override this brake and reinvigorate the immune response.